Eric Topol sur Twitter : “New NEJM: mRNA vaccine (@BioNTech_Group/Pfizer) holds up very well in lab studies for immune response against B.1. 526 (New York), B.1.429 (California), B.1.1.7(UK)+ E484K #variants 👍” / Twitter
▻https://twitter.com/EricTopol/status/1392585566324068358
BNT162b2-Elicited Neutralization against New SARS-CoV-2 Spike Variants | NEJM
▻https://www.nejm.org/doi/full/10.1056/NEJMc2106083
